Filing Details
- Accession Number:
- 0001127602-20-015824
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-07 18:02:03
- Reporting Period:
- 2020-05-05
- Accepted Time:
- 2020-05-07 18:02:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1739307 | A Brett Pletcher | 333 Lakeside Drive Foster City CA 94404 | Evp,Corp Affairs & Gen Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-05 | 12,560 | $40.56 | 27,204 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-05 | 650 | $24.30 | 27,854 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-05 | 13,210 | $79.23 | 14,644 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-05-05 | 12,560 | $0.00 | 12,560 | $40.56 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-05-05 | 650 | $0.00 | 650 | $24.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-02-01 | No | 4 | M | Direct | |
| 0 | 2022-01-26 | No | 4 | M | Direct |
Footnotes
- The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- Sale prices reported for the transactions reported here range from $79.23 to $79.24. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Billionaire Hedge Funds
